Results 111 to 120 of about 28,806 (223)

Study on the performance enhancement of biomedical implants: in vitro test under UV irradiation of titanium anodised in mixed electrolyte [PDF]

, 2018
Titanium (Ti) recently has widely been used in the biomedical applications due to its high performance. Therefore, surface modifications of titanium have attracted a lot of interest to provide better osseointegration.
Elfallah, Saleh S Saleh
core  

Characteristics of the epidemic process of measles, rubella and mumps in Moscow and assessment of their seroprevalence at the present stage

Вопросы вирусологии
Introduction. The problem of vaccine-preventable infections requires assessing the state of herd immunity through serological monitoring. The aim. To study the epidemiological features of measles, rubella and mumps and to estimate their seroprevalence
Yana V. Simakova, Vladimir A. Gushchin, Tatiana A. Semenenko, Daria A. Ogarkova, Denis A. Kleymenov, Anna V. Nozdracheva, Victor A. Manuylov, Artem P. Tkachuk, Alexander L. Gintsburg   +8 more
doaj   +1 more source

Mumps vaccine effectiveness of a 3rd dose of measles, mumps, rubella vaccine in school settings during a mumps outbreak -- Arkansas, 2016-2017. [PDF]

Public Health Pract (Oxf), 2023
Guo A, Leung J, Ayers T, Fields VS, Safi H, Waters C, Curns AT, Routh JA, Haselow DT, Marlow MA, Marin M.   +10 more
europepmc   +1 more source

Prediction of Specific Antibody- and Cell-Mediated Responses Using Baseline Immune Status Parameters of Individuals Received Measles-Mumps-Rubella Vaccine. [PDF]

Viruses, 2023
Toptygina A, Grebennikov D, Bocharov G.
europepmc   +1 more source

Age Limit Does Not Replace Serologic Testing for Determination of Immune Status for Measles [PDF]

, 2017
Adults more than 40 years old are not necessarily immune to measles. A measles outbreak that involved healthcare workers occurred after contact with a 44-year-old patient.
Hugonnet, Stéphane, Kaiser, Laurent, Pittet, Didier, Sax, Hugo, Uçkay, Ilker   +4 more
core  

MEASLES-MUMPS-RUBELLA VACCINATION IN A PAEDIATRIC TRANSPLANT PATIENT USING EVEROLIMUS

İstanbul Tıp Fakültesi Dergisi
There is limited information regarding the administration of live vaccines to paediatric transplant patients who are at increased risk of infection. A 7-year-old liver transplant patient who had everolimus therapy was evaluated for Measles-Mumps-Rubella (
Aybüke Kaçır, Övgü Büke, Nalan Karabayır, Mine Başıbüyük, Demet Deniz Bilgin, Özlem Öcal   +5 more
doaj   +1 more source

Intralesional Immunotherapy with Measles-Mumps-Rubella Vaccine for Recalcitrant Facial Warts: A Report of Two Cases. [PDF]

Oman Med J, 2022
Al-Qassabi AM, Al Kindi A.
europepmc   +1 more source

The Influence of Sex, Body Mass Index, and Age on Cellular and Humoral Immune Responses Against Measles After a Third Dose of Measles-Mumps-Rubella Vaccine. [PDF]

J Infect Dis, 2022
Quach HQ, Chen J, Monroe JM, Ratishvili T, Warner ND, Grill DE, Haralambieva IH, Ovsyannikova IG, Poland GA, Kennedy RB.   +9 more
europepmc   +1 more source

MMR (measles-mumps-rubella) vaccine [PDF]

Paediatrics & Child Health, 2001
openaire   +2 more sources

Effect of Pentavac and measles-mumps-rubella (MMR) vaccination on the intestine [PDF]

, 2007
To access full text version of this article. Please click on the hyperlink "Full Text" at the bottom of this pageBACKGROUND: The safety of infant vaccination has been questioned in recent years. In particular it has been suggested that the measles, mumps,
Agnarsson, U, Bjarnason, I, Davidsdottir, K, Kjeld, M, Sigthorsson, G, Thjodleifsson, B   +5 more
core